title: Assessing clinically meaningful end points for the management of actinic keratosis with diclofenac 3% gel.
authors.forename: Jason K
authors.initials: JK
authors.lastname: Rivers
authors.forename: Jason J
authors.initials: JJ
authors.lastname: Rivers
authors.forename: John
authors.initials: J
authors.lastname: Wolf
mesh_terms: D000287:Administration, Topical; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D004008:Diclofenac / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D007642:Keratosis / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D004008:Diclofenac